← Back to Search

Diffusion-weighted imaging magnetic resonance imaging for Squamous Cell Carcinoma

N/A
Waitlist Available
Led By Gloria J Guzman Pérez-Carrillo, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-3 weeks post-standard of care treatment
Awards & highlights

Study Summary

This trial will use a new imaging technique to more accurately detect cancer recurrence and early non-responders to therapy in patients with squamous cell carcinoma of the neck.

Eligible Conditions
  • Squamous Cell Carcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-3 weeks post-standard of care treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-3 weeks post-standard of care treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Apparent diffusion coefficient lowest value in a tumor (ADCmin)
Apparent diffusion coefficient mean (ADCmean)
Secondary outcome measures
Number of non-responders to treatment as measured by DWI MRI as compared to the number of non-responders to treatment as measured by FDG PET/CT

Trial Design

1Treatment groups
Experimental Treatment
Group I: DWI MRIExperimental Treatment1 Intervention
-The patients will undergo an optimized research neck DWI MRI, up to 3 weeks post-treatment and then a standard-of-care 3-month post-treatment FDG PET/CT examination.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,944 Previous Clinical Trials
2,304,485 Total Patients Enrolled
Gloria J Guzman Pérez-Carrillo, M.D.Principal InvestigatorWashington University School of Medicine

Media Library

Diffusion-weighted imaging magnetic resonance imaging Clinical Trial Eligibility Overview. Trial Name: NCT04685798 — N/A
Squamous Cell Carcinoma Research Study Groups: DWI MRI
Squamous Cell Carcinoma Clinical Trial 2023: Diffusion-weighted imaging magnetic resonance imaging Highlights & Side Effects. Trial Name: NCT04685798 — N/A
Diffusion-weighted imaging magnetic resonance imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT04685798 — N/A
~2 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top